William H. Bisson

6.6k total citations · 1 hit paper
50 papers, 3.2k citations indexed

About

William H. Bisson is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Oncology. According to data from OpenAlex, William H. Bisson has authored 50 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Health, Toxicology and Mutagenesis and 7 papers in Oncology. Recurrent topics in William H. Bisson's work include Toxic Organic Pollutants Impact (10 papers), Effects and risks of endocrine disrupting chemicals (9 papers) and Estrogen and related hormone effects (6 papers). William H. Bisson is often cited by papers focused on Toxic Organic Pollutants Impact (10 papers), Effects and risks of endocrine disrupting chemicals (9 papers) and Estrogen and related hormone effects (6 papers). William H. Bisson collaborates with scholars based in United States, Switzerland and Italy. William H. Bisson's co-authors include Siva K. Kolluri, Daniel C. Koch, Roderick H. Dashwood, Shantu Amin, Andrew D. Patterson, Robert L. Tanguay, Gary H. Perdew, Nancy I. Kerkvliet, David E. Williams and Iain A. Murray and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

William H. Bisson

50 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction

2015 455 citations Cen Xie, Kristopher W. Krausz et al. profile →

Peers

Countries citing papers authored by William H. Bisson

Since Specialization

Citations

This map shows the geographic impact of William H. Bisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Bisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Bisson more than expected).

Fields of papers citing papers by William H. Bisson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Bisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Bisson. The network helps show where William H. Bisson may publish in the future.

Co-authorship network of co-authors of William H. Bisson

This figure shows the co-authorship network connecting the top 25 collaborators of William H. Bisson. A scholar is included among the top collaborators of William H. Bisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. Bisson. William H. Bisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase 2022 ·ACS Omega ·Luca Mologni, Sébastien Tardy, Alfonso Zambon, Alexandre Orsato, William H. Bisson, Monica Ceccon, (unknown), (unknown), (unknown), (unknown), (unknown), Peter G. Goekjian, Léonardo Scapozza, Carlo Gambacorti‐Passerini	10
2	Structure-Activity Relationships of the Main Bioactive Constituents of Euodia rutaecarpa on Aryl Hydrocarbon Receptor Activation and Associated Bile Acid Homeostasis 2018 ·Drug Metabolism and Disposition ·You-Bo Zhang, Tingting Yan, Dongxue Sun, Cen Xie, (unknown), Lei Zhang, Tomoki Yagai, Kristopher W. Krausz, William H. Bisson, Xiu‐Wei Yang, Frank J. Gonzalez	23
3	Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions 2017 ·Cellular and Molecular Gastroenterology and Hepatology ·Luai Zarour, Sudarshan Anand, Kevin G. Billingsley, William H. Bisson, Andrea Cercek, Michael F. Clarke, Lisa M. Coussens, Charles E. Gast, Cristina B. Geltzeiler, Lissi Hansen, Katherine A. Kelley, Charles D. Lopez, Shushan Rana, Rebecca Ruhl, Vassiliki L. Tsikitis, Gina M. Vaccaro, Melissa H. Wong, Skye C. Mayo	198
4	Mechanistic Investigations Into the Developmental Toxicity of Nitrated and Heterocyclic PAHs 2017 ·Toxicological Sciences ·Anna C. Chlebowski, Gloria R. Garcia, Jane K. La Du, William H. Bisson, Lisa Truong, Staci L. Massey Simonich, Robert L. Tanguay	47
5	Divergent Ah Receptor Ligand Selectivity during Hominin Evolution 2016 ·Molecular Biology and Evolution ·Troy D. Hubbard, Iain A. Murray, William H. Bisson, Alexis Sullivan, Aswathy Sebastian, George H. Perry, Nina G. Jablonski, Gary H. Perdew	54
6	Low-Dose Mixture Hypothesis of Carcinogenesis Workshop: Scientific Underpinnings and Research Recommendations 2016 ·Environmental Health Perspectives ·Mark F. Miller, William H. Goodson, Masoud H. Manjili, Nicole Kleinstreuer, William H. Bisson, Leroy Lowe	27
7	Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors 2015 ·Current Topics in Medicinal Chemistry ·Eunah Kim, William H. Bisson, Christiane V. Löhr, David E. Williams, Emily Ho, Roderick H. Dashwood, Praveen Rajendran	61
8	Ligand-Specific Transcriptional Mechanisms Underlie Aryl Hydrocarbon Receptor-Mediated Developmental Toxicity of Oxygenated PAHs 2015 ·Toxicological Sciences ·Britton C. Goodale, (unknown), Susan C. Tilton, Christopher M. Sullivan, William H. Bisson, Katrina M. Waters, Robert L. Tanguay	58
9	Differences in Conformational Dynamics between Plasmodium falciparum and Human Hsp90 Orthologues Enable the Structure-Based Discovery of Pathogen-Selective Inhibitors 2014 ·Journal of Medicinal Chemistry ·Tai Wang, William H. Bisson, Pascal Mäser, Léonardo Scapozza, Didier Picard	39
10	HDAC8 and STAT3 repress BMF gene activity in colon cancer cells 2014 ·Cell Death and Disease ·(unknown), Hui Nian, Praveen Rajendran, (unknown), Wan Mohaiza Dashwood, John T. Pinto, Lisa A. Boardman, Steven Thibodeau, Paul J. Limburg, Christiane V. Löhr, William H. Bisson, David E. Williams, Emily Ho, Roderick H. Dashwood	65
11	Mono-substituted isopropylated triaryl phosphate, a major component of Firemaster 550, is an AHR agonist that exhibits AHR-independent cardiotoxicity in zebrafish 2014 ·Aquatic Toxicology ·(unknown), Siba R. Das, David C. Volz, William H. Bisson, Siva K. Kolluri, Robert L. Tanguay	34
12	Crizotinib-Resistant NPM-ALK Mutants Confer Differential Sensitivity to Unrelated Alk Inhibitors 2012 ·Molecular Cancer Research ·Monica Ceccon, Luca Mologni, William H. Bisson, Léonardo Scapozza, Carlo Gambacorti‐Passerini	71
13	Alternate glucocorticoid receptor ligand binding structures influence outcomes in an in vivo tissue regeneration model 2012 ·Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology ·S. Sengupta, William H. Bisson, Lijoy K. Mathew, Siva K. Kolluri, Robert L. Tanguay	19
14	Drug Repurposing in Chemical Genomics: Can We Learn from the Past to Improve the Future? 2012 ·Current Topics in Medicinal Chemistry ·William H. Bisson	21
15	AHR2 Mutant Reveals Functional Diversity of Aryl Hydrocarbon Receptors in Zebrafish 2012 ·PLoS ONE ·Britton C. Goodale, Jane K. La Du, William H. Bisson, Derek B. Janszen, Katrina M. Waters, Robert L. Tanguay	72
16	Suppression of Cytokine-Mediated Complement Factor Gene Expression through Selective Activation of the Ah Receptor with 3′,4′-Dimethoxy-α-naphthoflavone 2010 ·Molecular Pharmacology ·Iain A. Murray, Colin A. Flaveny, Christopher Chiaro, Arun Sharma, (unknown), Jennifer C. Schroeder, Shantu Amin, William H. Bisson, Siva K. Kolluri, Gary H. Perdew	42
17	Estrogen-Like Activity of Perfluoroalkyl Acids In Vivo and Interaction with Human and Rainbow Trout Estrogen Receptors In Vitro 2010 ·Toxicological Sciences ·Abby D. Benninghoff, William H. Bisson, Daniel C. Koch, David J. Ehresman, Siva K. Kolluri, David E. Williams	207
18	Homology modeling and dynamics of the extracellular domain of rat and human neuronal nicotinic acetylcholine receptor subtypes α4β2 and α7 2008 ·Journal of Molecular Modeling ·William H. Bisson, G. Westera, P. A. Schubiger, Léonardo Scapozza	19
19	Molecular basis of agonicity and antagonicity in the androgen receptor studied by molecular dynamics simulations 2008 ·Journal of Molecular Graphics and Modelling ·William H. Bisson, Ruben Abagyan, Claudio N. Cavasotto	26
20	Binding Properties of the C‐terminal Domain of VIAF 2008 ·Chemical Biology & Drug Design ·William H. Bisson, Ziming Zhang, Kate Welsh, (unknown), Jennifer J. Ryan, John C. Reed, Maurizio Pellecchia	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact